Blonanserin’s interesting food-effect observations: is lymphatic transport involved?
- 6 April 2011
- journal article
- letter
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 67 (9) , 975-976
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effect of dose timing in relation to food intake on systemic exposure to blonanserinEuropean Journal of Clinical Pharmacology, 2010
- The Role of the Intestinal Lymphatics in the Absorption of Two Highly Lipophilic Cholesterol Ester Transfer Protein Inhibitors (CP524,515 and CP532,623)Pharmaceutical Research, 2010
- Intestinal lipid absorptionAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass MetabolismPharmaceutical Research, 2009
- Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: Dexanabinol and PRS-211,220European Journal of Pharmaceutical Sciences, 2007
- The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut LumenPharmaceutical Research, 2005
- Intestinal lymphatic drug transport: an updateAdvanced Drug Delivery Reviews, 2001